Clinical Trials
64 trialsOMEC-5
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors
LARKSPUR BIOSCIENCES, INC.
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Daiichi Sankyo
RAPID
Children's Hospital Los Angeles
Anti-PD-1 Antibody Alone or in Combination With Decitabine/Chemotherapy in Relapsed or Refractory Malignancies
Chinese PLA General Hospital
Comparing 68Ga-FAPI PET-Guided Abdominal Radiotherapy Combined With Second-Line Standard Therapy and Cadonilimab Versus Second-Line Standard Therapy in Colorectal Cancer With Peritoneal Metastasis
Fudan University
Cryopreservation of Ovarian Tissue
Weill Medical College of Cornell University
HYPERBOLIC
Università Vita-Salute San Raffaele
Pan-MSI-ACSE
UNICANCER
KYANITE-1
Krystal Biotech, Inc.
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
University of California, San Diego
AVR-CHEMO
Arab American University (Palestine)
SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.
Drugs-SNPs
Medicine Invention Design, Inc
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
DEKA Biosciences
CaSPiN
Turku University Hospital
Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China
RenJi Hospital
SOCCER-P
Korea University Guro Hospital
BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors
BPGbio
ROOT
Taproot Health
A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer
Mabwell (Shanghai) Bioscience Co., Ltd.
IO-001
iTeos Therapeutics
Effects of Chemotherapy on Perceived Daily Performance and Executive Functions of Adults With Cancer
Bnai Zion Medical Center
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
Persephone Biosciences
Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases
Capital Medical University
ENDOVIE
ARCAGY/ GINECO GROUP
A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies
AbbVie
COLT
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN
University of Kentucky
GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer
Genelux Corporation
Clinical Observation of Integrated Chinese Medicine With Western Medicine for the Reduction of Chemotherapy-induced Hematologic Toxicity
Taichung Tzu Chi Hospital
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
State Scientific Centre of Coloproctology, Russian Federation
Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary
Shanghai Changzheng Hospital
Improving Informed Consent for Palliative Chemotherapy
Dana-Farber Cancer Institute
A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic Lymphoma
AbbVie
Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer
Xi'an Jiaotong University
CICARO
Charite University, Berlin, Germany
PROTACT
Silenseed Ltd
Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study
First Affiliated Hospital of Harbin Medical University
Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
Aduro Biotech, Inc.
Study of DC Vaccination Against Glioblastoma
Huashan Hospital
PRESOV
Assistance Publique - Hôpitaux de Paris
Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma
Oncolytics Biotech
ECLIPSE
Aduro Biotech, Inc.
GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma
GlaxoSmithKline
NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer
University of Kentucky
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Vanderbilt University Medical Center
ECHO
National Cancer Center, Korea
Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma
University of Utah
Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Amgen